Linguistically Tailored Health Messages to Encourage Plant-Based Food Choices in Adolescents
Launched by ERASMUS UNIVERSITY ROTTERDAM · Dec 16, 2024
Trial Information
Current as of July 04, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This study is a five-arm randomized controlled trial targeting adolescents aged 11-16 years in the UK and Ireland. In the intervention arms, participants will receive daily messages promoting a plant-based diet from Monday to Friday for two weeks. The first arm serves as a passive control group, with participants receiving no messages throughout the study. In arm 2, participants will receive daily non-tailored messages for the entire two weeks. In arm 3, participants will receive linguistically tailored messages. Participants in arm 4 will receive both non-tailored and tailored messages for...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged 11-16 years
- • Residing in the UK or Ireland
- • Having access to plant-based food options during school hours (e.g., provided by the school, purchased, or brought from home or a store)
- Exclusion Criteria:
- • • Adolescents who follow a strict vegetarian or vegan diet
About Erasmus University Rotterdam
Erasmus University Rotterdam is a leading academic institution in the Netherlands, renowned for its commitment to excellence in research and education. With a strong focus on health sciences, the university actively engages in clinical trials to advance medical knowledge and improve patient care. Its multidisciplinary approach fosters collaboration among experts in various fields, ensuring that trials are designed and conducted with the highest standards of scientific rigor and ethical consideration. By leveraging its extensive resources and innovative methodologies, Erasmus University Rotterdam aims to contribute significantly to the development of effective treatments and interventions in the healthcare sector.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , Ireland
London, , United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported